Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Leukemia, Myelogenous, Chronic, BCR-ABL Positive × Educational Status × 90 days × Clear all

Sponsor

Conditions

Colorectal Neoplasms 8 Breast Neoplasms 7 Lung Neoplasms 6 Prostatic Neoplasms 4 Obesity-Related Malignant Neoplasm 3 Neoplasm Metastasis 3 Lymphoma 3 Hematopoietic and Lymphatic System Neoplasm 3 Triple Negative Breast Neoplasms 2 Skin Carcinoma 2 Papillomavirus Infections 2 Hematologic Neoplasms 2 Anatomic Stage I Breast Cancer AJCC v8 2 Vulvar Neoplasms 1 Vaginal Neoplasms 1 Uveal Melanoma 1 Uterine Cervical Neoplasms 1 Testicular Neoplasms 1 Substance-Related Disorders 1 Sarcoma 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Ovarian Neoplasms 1 Opioid-Related Disorders 1 Neoplasms 1 Lymphoma, Follicular 1 Leukemia, Myeloid, Acute 1 Inflammatory Breast Neoplasms 1 Glioblastoma 1 Genital Neoplasms, Female 1 Gastrointestinal Neoplasms 1

Interventions

Cyclophosphamide 11 fludarabine 10 fludarabine phosphate 8 asciminib 7 Whole-Body Irradiation 7 Mycophenolic Acid 7 Tacrolimus 6 Melphalan 5 Busulfan 5 nilotinib 4 Mesna 4 Granulocyte Colony-Stimulating Factor 4 Dasatinib 4 Imatinib Mesylate 3 Filgrastim 3 olverembatinib 2 bosutinib 2 Thiotepa 2 Stem Cell Transplantation 2 Peripheral Blood Stem Cell Transplantation 2 Patient Reported Outcome Measures 2 Magnetic Resonance Spectroscopy 2 Cyclosporine 2 Bone Marrow Transplantation 2 venetoclax 1 treosulfan 1 thymoglobulin 1 ruxolitinib 1 ponatinib 1 blinatumomab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡